Hillsdale Investment Management Inc. Applied Genetic Technologies Corp Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$2.69 - $4.92 $16,409 - $30,012	-6,100 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$2.59 - $4.16 $15,799 - $25,376	6,100 New	6,100 $25,000
Q1 2019 May 13, 2019	SELL	$2.62 - $4.44 $61,344 - $103,958	-23,414 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$2.28 - $7.15 $53,383 - $167,410	23,414 New	23,414 $58,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.